2018
DOI: 10.3389/fneur.2018.00906
|View full text |Cite
|
Sign up to set email alerts
|

The Neuromodulatory Impact of Subthalamic Nucleus Deep Brain Stimulation on Gait and Postural Instability in Parkinson's Disease Patients: A Prospective Case Controlled Study

Abstract: Background: Subthalamic nucleus deep brain stimulation (STN-DBS) has been an established method in improvement of motor disabilities in Parkinson's disease (PD) patients. It has been also claimed to have an impact on balance and gait disorders in PD patients, but the previous results are conflicting.Objective: The aim of this prospective controlled study was to evaluate the impact of STN-DBS on balance disorders in PD patients in comparison with Best-Medical-Therapy (BMT) and Long-term-Post-Operative (POP) gro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

1
20
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(21 citation statements)
references
References 31 publications
1
20
0
Order By: Relevance
“…Trunk position in PD has been measured or assumed from muscle echo intensity of the abdominal wall [ 18 ], from review of video recordings [ 4 , 19 ], subjectively using the 0–4 MDS Unified Parkinson’s Disease Rating Scale [ 20 22 ], or through observation [ 23 ]. Here, we use objective ultrasound motion detection to study and quantify alterations of body position in patients with PD and consider the longer-term effectiveness of DBS in the STN.…”
Section: Introductionmentioning
confidence: 99%
“…Trunk position in PD has been measured or assumed from muscle echo intensity of the abdominal wall [ 18 ], from review of video recordings [ 4 , 19 ], subjectively using the 0–4 MDS Unified Parkinson’s Disease Rating Scale [ 20 22 ], or through observation [ 23 ]. Here, we use objective ultrasound motion detection to study and quantify alterations of body position in patients with PD and consider the longer-term effectiveness of DBS in the STN.…”
Section: Introductionmentioning
confidence: 99%
“…The ratio of single support time (SST) and double support time (DST) is consistent in a healthy population (4:1) [13,14]; in PD the DST is more lengthy [4,[15][16][17][18][19][20]. The PD gait is shuffling and slow, and the stride is shorter [7,18,20,21], although it sustains its natural width [18]. Contrary to a vastly accepted concept of decreased joint range in limbs during gait based on some published results [17,21], a meta-analysis found no significant decrease in range of motion (ROM) in any joint except the hip joint [18].…”
Section: Introductionmentioning
confidence: 99%
“…Pathology of the disease consists of loss of dopaminergic neurons in the brainstem and their projections to basal ganglia deterioration between excitatory and inhibitory neural oscillators [3] that leads to inappropriate extent and timing of movement sequences [4,5]. In addition to the cardinal motor symptoms (rest tremor, muscle rigidity, and bradykinesia), fatigue [1,6], postural instability [1,7], problems in turning [1,8], standing up, or movement initiation [1,9], and/or freezing of gait [1,10] are associated with the disease. All these symptoms disrupt the gait cycle [1,[6][7][8][9][10][11][12].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Regarding current therapeutic interventions, levodopa and deep-brain stimulation (DBS) therapies do not effectively improve balance control in PD in the disease progress and no long-term efficacy of either therapy has been proven for PD postural instability (13)(14)(15)(16). This instability may be related to dopaminergic disruption to the neural integration of jerk or sway.…”
Section: Introductionmentioning
confidence: 99%